FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013860462> ?p ?o ?g. }

• W2013860462 endingPage "87" @default.
• W2013860462 startingPage "77" @default.
• W2013860462 abstract "FR74366 (FK366) {[3-(4-bromo-2-fluorobenzyl)-7-chloro-2,4-dioxo-1,2,3,4-tetrahydroquinazolin- 1-yl] acetic acid} is a chemically novel aldose reductase (AR) inhibitor. It exhibited a highly potent, reversible, and mixed type inhibition of partially purified AR from the rat sciatic nerve (IC50 = 3.6 nmol/L) and rat lens (IC50 = 4.4 nmol/L). FR74366 inhibited sorbitol accumulation in the isolated human erythrocyte (IC50 = 1.6 μmol/L), rat lens (IC50 = 39 μmol/L), and rat sciatic nerve (IC50 = 17 μmol/L) incubated with high glucose concentrations. The oral administration of FR74366 to streptozotocin (STZ)-induced diabetic rats for 2 weeks decreased sorbitol levels (ED50 = 3.7 mg/kg for sciatic nerve, 23 mg/kg for lens, 52 mg/kg for retina, and 62 mg/kg for renal cortex). Administration of FR74366 to diabetic rats for 17 weeks delayed cataract formation and admixture of 0.028% FR74366 in the diet completely inhibited the cataract formation. Moreover, the recovery of reduced motor nerve conduction velocity by FR74366 in diabetic rats was demonstrated in prevention and reversal experiments. This recovery effect correlated well with reduction of accumulated sorbitol and fructose levels and normalization of decreased myoinositol levels. The duration and tissue specificity of inhibitory effects of FR74366 on sorbitol accumulation also correlated well with the levels of FR74366 in various tissues of diabetic rats. These data indicate that both decreases in tissue sorbitol levels and improvement of functional defects reflect FR74366 levels in tissue rather than plasma in diabetic rats. These results, taken together, suggest that FR74366, which is currently undergoing clinical trials in Japan and the United States, will be a useful therapeutic agent for diabetic complications." @default.
• W2013860462 created "2016-06-24" @default.
• W2013860462 creator A5012115431 @default.
• W2013860462 creator A5016089359 @default.
• W2013860462 creator A5018972430 @default.
• W2013860462 creator A5024796120 @default.
• W2013860462 creator A5027930349 @default.
• W2013860462 creator A5031896425 @default.
• W2013860462 creator A5034779904 @default.
• W2013860462 creator A5077288845 @default.
• W2013860462 creator A5081953127 @default.
• W2013860462 date "1991-01-01" @default.
• W2013860462 modified "2023-10-14" @default.
• W2013860462 title "Characterization of a novel aldose reductase inhibitor, FR74366, and its effects on diabetic cataract and neuropathy in the rat" @default.
• W2013860462 cites W1501604225 @default.
• W2013860462 cites W1539934907 @default.
• W2013860462 cites W1683425866 @default.
• W2013860462 cites W1966083787 @default.
• W2013860462 cites W1966353608 @default.
• W2013860462 cites W1968415431 @default.
• W2013860462 cites W1969488647 @default.
• W2013860462 cites W1970096972 @default.
• W2013860462 cites W1983680438 @default.
• W2013860462 cites W1996424575 @default.
• W2013860462 cites W1996513950 @default.
• W2013860462 cites W1996741922 @default.
• W2013860462 cites W2004485769 @default.
• W2013860462 cites W2005894959 @default.
• W2013860462 cites W2025524615 @default.
• W2013860462 cites W2027259499 @default.
• W2013860462 cites W2030157332 @default.
• W2013860462 cites W2035263709 @default.
• W2013860462 cites W2037472087 @default.
• W2013860462 cites W2038611882 @default.
• W2013860462 cites W2039115551 @default.
• W2013860462 cites W2050953222 @default.
• W2013860462 cites W2059273331 @default.
• W2013860462 cites W2067323403 @default.
• W2013860462 cites W2068786544 @default.
• W2013860462 cites W2073505541 @default.
• W2013860462 cites W2078083049 @default.
• W2013860462 cites W2100973036 @default.
• W2013860462 cites W2116649852 @default.
• W2013860462 cites W2157296179 @default.
• W2013860462 cites W2161003385 @default.
• W2013860462 cites W2165646315 @default.
• W2013860462 cites W2210821517 @default.
• W2013860462 cites W2313945403 @default.
• W2013860462 cites W2321278054 @default.
• W2013860462 cites W2323811200 @default.
• W2013860462 cites W4232903554 @default.
• W2013860462 cites W4240827493 @default.
• W2013860462 cites W4244024763 @default.
• W2013860462 cites W4250147121 @default.
• W2013860462 cites W4253444307 @default.
• W2013860462 cites W4256235746 @default.
• W2013860462 doi "https://doi.org/10.1016/0026-0495(91)90196-4" @default.
• W2013860462 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1898618" @default.
• W2013860462 hasPublicationYear "1991" @default.
• W2013860462 type Work @default.
• W2013860462 sameAs 2013860462 @default.
• W2013860462 citedByCount "68" @default.
• W2013860462 countsByYear W20138604622012 @default.
• W2013860462 countsByYear W20138604622013 @default.
• W2013860462 countsByYear W20138604622014 @default.
• W2013860462 countsByYear W20138604622015 @default.
• W2013860462 countsByYear W20138604622016 @default.
• W2013860462 countsByYear W20138604622017 @default.
• W2013860462 countsByYear W20138604622018 @default.
• W2013860462 countsByYear W20138604622019 @default.
• W2013860462 countsByYear W20138604622020 @default.
• W2013860462 countsByYear W20138604622021 @default.
• W2013860462 countsByYear W20138604622022 @default.
• W2013860462 countsByYear W20138604622023 @default.
• W2013860462 crossrefType "journal-article" @default.
• W2013860462 hasAuthorship W2013860462A5012115431 @default.
• W2013860462 hasAuthorship W2013860462A5016089359 @default.
• W2013860462 hasAuthorship W2013860462A5018972430 @default.
• W2013860462 hasAuthorship W2013860462A5024796120 @default.
• W2013860462 hasAuthorship W2013860462A5027930349 @default.
• W2013860462 hasAuthorship W2013860462A5031896425 @default.
• W2013860462 hasAuthorship W2013860462A5034779904 @default.
• W2013860462 hasAuthorship W2013860462A5077288845 @default.
• W2013860462 hasAuthorship W2013860462A5081953127 @default.
• W2013860462 hasConcept C126322002 @default.
• W2013860462 hasConcept C134018914 @default.
• W2013860462 hasConcept C136502266 @default.
• W2013860462 hasConcept C185592680 @default.
• W2013860462 hasConcept C202751555 @default.
• W2013860462 hasConcept C2776439734 @default.
• W2013860462 hasConcept C2776779347 @default.
• W2013860462 hasConcept C2776970464 @default.
• W2013860462 hasConcept C2777056448 @default.
• W2013860462 hasConcept C2777374081 @default.
• W2013860462 hasConcept C2777752497 @default.
• W2013860462 hasConcept C2779280383 @default.
• W2013860462 hasConcept C2781149210 @default.
• W2013860462 hasConcept C55493867 @default.

• next